Narlumosbart
Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL) [1].
Product Specifications
CAS Number
2646587-68-8
UNSPSC
12352203
Target
RANKL/RANK
Type
Inhibitory Antibodies
Related Pathways
NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/narlumosbart.html
Purity
97.00
Solubility
10 mM in DMSO
Smiles
[Narlumosbart]
Molecular Weight
(144.886 kDa)
References & Citations
[1]Kaplon H, Crescioli S, Chenoweth A, Visweswaraiah J, Reichert JM. Antibodies to watch in 2023. MAbs. 2023 Jan-Dec;15 (1) :2153410.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
